Effects of vildagliptin on wound healing and markers of inflammation in patients with type 2 diabetic foot ulcer: a prospective, randomized, double-blind, placebo-controlled, single-center study

INTRODUCTION: Diabetic foot ulcers (DFU) are one of the leading long-term complications experienced by patients with diabetes. Dipeptidyl Peptidase 4 inhibitors (DPP4is) are a class of antihyperglycemic medications prescribed to patients with diabetes to manage glycaemic control. DPP4is may also hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Vangaveti, Venkat N., Jhamb, Shaurya, Hayes, Oliver, Goodall, Julie, Bulbrook, Jacqueline, Robertson, Kelvin, Biros, Erik, Sangla, Kunwarjit S., Malabu, Usman H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716851/
https://www.ncbi.nlm.nih.gov/pubmed/36456992
http://dx.doi.org/10.1186/s13098-022-00938-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716851/
https://www.ncbi.nlm.nih.gov/pubmed/36456992
http://dx.doi.org/10.1186/s13098-022-00938-2

Ejemplares similares